| Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer PC Hermann, SL Huber, T Herrler, A Aicher, JW Ellwart, M Guba, ... Cell stem cell 1 (3), 313-323, 2007 | 3638 | 2007 |
| Reduced exposure to calcineurin inhibitors in renal transplantation H Ekberg, H Tedesco-Silva, A Demirbas, Š Vítko, B Nashan, A Gürkan, ... New England Journal of Medicine 357 (25), 2562-2575, 2007 | 2302 | 2007 |
| Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor M Guba, P Von Breitenbuch, M Steinbauer, G Koehl, S Flegel, M Hornung, ... Nature medicine 8 (2), 128-135, 2002 | 2238 | 2002 |
| Pro-and anti-cancer effects of immunosuppressive agents used in organ transplantation M Guba, C Graeb, KW Jauch, EK Geissler Transplantation 77 (12), 1777-1782, 2004 | 459 | 2004 |
| Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data GA Knoll, MB Kokolo, R Mallick, A Beck, CD Buenaventura, R Ducharme, ... Bmj 349, 2014 | 362 | 2014 |
| Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion D DuBay, C Sandroussi, L Sandhu, S Cleary, M Guba, MS Cattral, ... Annals of surgery 253 (1), 166-172, 2011 | 329 | 2011 |
| Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice GE Koehl, J Andrassy, M Guba, S Richter, A Kroemer, MN Scherer, ... Transplantation 77 (9), 1319-1326, 2004 | 290 | 2004 |
| Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread E Pretzsch, F Bösch, J Neumann, P Ganschow, A Bazhin, M Guba, ... Journal of oncology 2019 (1), 7407190, 2019 | 288 | 2019 |
| The janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich CD Wimmer, M Rentsch, A Crispin, WD Illner, H Arbogast, C Graeb, ... Kidney international 71 (12), 1271-1278, 2007 | 247 | 2007 |
| Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis S Huber, CJ Bruns, G Schmid, PC Hermann, C Conrad, H Niess, R Huss, ... Kidney international 71 (8), 771-777, 2007 | 245 | 2007 |
| Vascular endothelial growth factor in esophageal cancer A Kleespies, M Guba, KW Jauch, CJ Bruns Journal of surgical oncology 87 (2), 95-104, 2004 | 239 | 2004 |
| Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation … Z Czigany, J Pratschke, J Froněk, M Guba, W Schöning, DA Raptis, ... Annals of surgery 274 (5), 705-712, 2021 | 197 | 2021 |
| Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF M Guba, M Yezhelyev, ME Eichhorn, G Schmid, I Ischenko, A Papyan, ... Blood 105 (11), 4463-4469, 2005 | 186 | 2005 |
| A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis M Guba, G Cernaianu, G Koehl, EK Geissler, KW Jauch, M Anthuber, ... Cancer Research 61 (14), 5575-5579, 2001 | 162 | 2001 |
| Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis H Seeliger, M Guba, A Kleespies, KW Jauch, CJ Bruns Cancer and Metastasis Reviews 26, 611-621, 2007 | 153 | 2007 |
| Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice MV Yezhelyev, G Koehl, M Guba, T Brabletz, KW Jauch, A Ryan, A Barge, ... Clinical Cancer Research 10 (23), 8028-8036, 2004 | 152 | 2004 |
| Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer CJ Bruns, GE Koehl, M Guba, M Yezhelyev, M Steinbauer, H Seeliger, ... Clinical cancer research 10 (6), 2109-2119, 2004 | 149 | 2004 |
| Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer PC Manegold, C Paringer, U Kulka, K Krimmel, ME Eichhorn, R Wilkowski, ... Clinical Cancer Research 14 (3), 892-900, 2008 | 138 | 2008 |
| The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases L An, U Wirth, D Koch, M Schirren, M Drefs, D Koliogiannis, H Nieß, ... Journal of Gastrointestinal Surgery 26 (3), 671-683, 2022 | 131 | 2022 |
| Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients … M Guba, J Pratschke, C Hugo, BK Krämer, C Nohr-Westphal, ... Transplantation 90 (2), 175-183, 2010 | 131 | 2010 |
